Pharmacologic reversal of hypotensive effect complicating antiarrhythmic therapy with bretylium.
D000284:Administration, Oral; D000320:Adrenergic Fibers / Q000187:drug effects; D000328:Adult; D000368:Aged; D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001949:Bretylium Compounds / Q000627:therapeutic use*; D001950:Bretylium Tosylate / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D003986:Dibenzocycloheptenes / Q000627:therapeutic use*; D004562:Electrocardiography; D006801:Humans; D007024:Hypotension, Orthostatic / Q000139:chemically induced* / Q000188:drug therapy; D008875:Middle Aged; D011530:Protriptyline / Q000627:therapeutic use*; D014690:Venous Pressure / Q000187:drug effects
D000929:Antidepressive Agents, Tricyclic; D001949:Bretylium Compounds; D003986:Dibenzocycloheptenes; D011530:Protriptyline; D001950:Bretylium Tosylate